- Home
- MESA vs CUE Comparison
MESA vs CUE Comparison
Compare MESA & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- CUE
- Stock Information
- Founded
- MESA 1982
- CUE 2014
- Country
- MESA United States
- CUE United States
- Employees
- MESA N/A
- CUE N/A
- Industry
- MESA Air Freight/Delivery Services
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- CUE Health Care
- Exchange
- MESA Nasdaq
- CUE Nasdaq
- Market Cap
- MESA 59.5M
- CUE 61.1M
- IPO Year
- MESA 2018
- CUE 2018
- Fundamental
- Price
- MESA $1.45
- CUE $0.79
- Analyst Decision
- MESA
- CUE Strong Buy
- Analyst Count
- MESA 0
- CUE 2
- Target Price
- MESA N/A
- CUE $3.00
- AVG Volume (30 Days)
- MESA 130.9K
- CUE 287.6K
- Earning Date
- MESA 11-13-2025
- CUE 11-13-2025
- Dividend Yield
- MESA N/A
- CUE N/A
- EPS Growth
- MESA N/A
- CUE N/A
- EPS
- MESA N/A
- CUE N/A
- Revenue
- MESA $406,021,000.00
- CUE $8,286,000.00
- Revenue This Year
- MESA $39.81
- CUE N/A
- Revenue Next Year
- MESA N/A
- CUE N/A
- P/E Ratio
- MESA N/A
- CUE N/A
- Revenue Growth
- MESA N/A
- CUE N/A
- 52 Week Low
- MESA $0.68
- CUE $0.54
- 52 Week High
- MESA $1.50
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- MESA 61.28
- CUE 51.54
- Support Level
- MESA $1.38
- CUE $0.76
- Resistance Level
- MESA $1.48
- CUE $0.84
- Average True Range (ATR)
- MESA 0.07
- CUE 0.07
- MACD
- MESA 0.00
- CUE -0.00
- Stochastic Oscillator
- MESA 77.27
- CUE 31.01
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.